Loading…
A physician-facing workshop on combining conventional oncology with repurposed off-label drugs, diet, fasting and lab monitoring — presented by Dr. Homer Lim across a morning and an afternoon session.
This workshop was written and delivered for physicians, not for patients or family members. It is clinician-facing content, delivered to physicians managing individual patients — every drug, dose and timing decision described in it was made by clinicians with full access to labs, imaging and medical history for a specific patient. None of it is a self-directed protocol for a patient or family member to assemble alone.
This is a full-day clinician workshop — a morning and an afternoon session — on combining conventional cancer treatment with "repurposed" drugs: everyday medicines already approved for other conditions (antiparasitics, diabetes drugs, cholesterol drugs, stomach-acid drugs, blood pressure drugs, antibiotics and others) that also appear to have anti-cancer effects, used alongside diet, fasting and lab-monitoring strategies. The stated rationale for repurposing rests on three practical arguments: these drugs already carry long safety track records, they sidestep the 10–20 years a new cancer drug typically takes to develop and trial, and because they are already registered they can be obtained at a regular pharmacy rather than through specialist hospital channels.
The morning session builds the biological case before any drug is named. It covers cancer stem cells and why they usually sit in bone marrow rather than the original tumour, cancer as a systemic disease with circulating tumour cells, the tumour microenvironment as the "soil", tumour heterogeneity, and metabolic plasticity — cancer's ability to switch fuel sources when one pathway is blocked. That last concept is the session's central argument for why single-target drugs and restrictive single-strategy diets tend to work for a while and then stop working.
The organising framework is what the workshop calls "press-pulse" therapy: a daily backbone of low-toxicity drugs that steadily reduce the fuel cancer cells depend on ("press"), combined with periodic, more intense interventions — chemotherapy, radiotherapy, high-dose IV vitamin C, hyperthermia, ozone, hyperbaric oxygen ("pulse"). The material is explicit that this is an adjunct strategy, not a replacement for conventional treatment.
The afternoon session turns to the pharmacology that makes this practicable: CYP450/CYP3A4 interactions, P-glycoprotein and the blood-brain barrier, chronotherapy, how doses are tapered by frequency rather than amount, drug-by-drug detail, lab monitoring between scans, and closing case studies and prescribing exercises. The material is notably candid about its own limits — it flags where the two sessions gave different figures for the same thing rather than reconciling them, and distinguishes real patient stories from hypothetical teaching cases.
This material is for general understanding and professional education only — it is not medical advice, and it is not a protocol for you to assemble, start, adjust, or administer yourself. Any patient should only start, stop, or adjust any of these drugs under the supervision of their treating doctor. This is not boilerplate caution: the workshop itself documents real cases of serious harm that occurred specifically because dosing decisions were made outside clinical supervision.
Dr. Homer Lim is a Filipino physician known for his work in integrative and complementary medicine, particularly integrative oncology, geriatrics and chronic degenerative disease care. He completed his medical education at the University of Santo Tomas in the Philippines, where he had earlier completed a degree in Medical Technology, and pursued formal study in gerontology and geriatrics through the Philippine College of Gerontology and Geriatrics. He is a geriatrician by training rather than an oncologist — a point he makes himself in this workshop, describing how he came to treat cancer patients because they kept arriving after failing conventional treatment or out of fear of chemotherapy and radiation. He is Founder and President of the Philippine Society of Orthomolecular Medicine (PSOM), President of the International Anti-Aging and Integrative Medicine Society, and lectures and runs workshops across the Philippines, Malaysia and Indonesia on nutrition, integrative cancer care, detoxification and orthomolecular medicine. In this workshop he states he has used repurposed drugs clinically for roughly ten years.
Pay once, and start watching — with a tutor that's already read every word of it.